Jihyun Kim

Jihyun Kim

Auto-generated profile, based on publicly available information

Jihyun Kim

Laboratory of Mucosal Immunology, Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
JHJongho Ham
Jongho Ham
JKJihyun Kim
Jihyun Kim
YKYoung Gyun Ko
Young Gyun Ko
HKHye Young Kim
Hye Young Kim
Ham J, et al. Allergy Asthma Immunol Res. 2022 Jul;14(4):361-378. https://doi.org/10.4168/aair.2022.14.4.361

22 December 2023 in Science Advances
Verified
Journal Article
Open access
JKJihyun Kim
Jihyun Kim
JHJongho Ham
Jongho Ham
HKHye Ryun Kang
Hye Ryun Kang
YBYong-Soo Bae
Yong-Soo Bae
TKTaeSoo Kim
TaeSoo Kim
HKHye Young Kim
Hye Young Kim
Steroids are the standard treatment for allergic airway inflammation in asthma, but steroid-refractory asthma poses a challenge. Group 2 innate lymphoid cells (ILC2s), such as T helper 2 (T H 2) cells, produce key asthma-related type 2 cytokines. Recent insights from mouse and human studies indicate a potential connection between ILC2s and steroid-resistant asthma. Here, we highlight that lung ILC2s, rather than T H 2 cells, can develop steroid resistance, allowing them to persist and maintain their disease-driving activity even during steroid treatment. The emergence of multipotent IL-5 + IL-13 + IL-17A + ILC2s is associated with steroid-resistant ILC2s. The Janus kinase 3 (JAK3)/signal transducer and activator of transcription (STAT) 3, 5, and 6 pathways contribute to the acquisition of steroid-resistant ILC2s. The JAK3 inhibitor reduces ILC2 survival, proliferation, and cytokine production in vitro and ameliorates ILC2-driven Alternaria -induced asthma. Furthermore, combining a JAK3 inhibitor with steroids results in the inhibition of steroid-resistant asthma. These findings suggest a potential therapeutic approach for addressing this challenging condition in chronic asthma.

4 July 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
JHJongho Ham
Jongho Ham
JKJihyun Kim
Jihyun Kim
KSKyoung‐Hee Sohn
Kyoung‐Hee Sohn
IPIn-Won Park
In-Won Park
BCByoung-Whui Choi
Byoung-Whui Choi
HKHye Young Kim
Hye Young Kim
Although cigarette smoking is known to exacerbate asthma, only a few clinical asthma studies have been conducted involving smokers. Here we show, by comparing paired sputum and blood samples from smoking and non-smoking patients with asthma, that smoking associates with significantly higher frequencies of pro-inflammatory, natural-cytotoxicity-receptor-non-expressing type 3 innate lymphoid cells (ILC3) in the sputum and memory-like, CD45RO-expressing ILC3s in the blood. These ILC3 frequencies positively correlate with circulating neutrophil counts and M1 alveolar macrophage frequencies, which are known to increase in uncontrolled severe asthma, yet do not correlate with circulating eosinophil frequencies that characterize allergic asthma. In vitro exposure of ILCs to cigarette smoke extract induces expression of the memory marker CD45RO in ILC3s. Cigarette smoke extract also impairs the barrier function of airway epithelial cells and increases their production of IL-1β, which is a known activating factor for ILC3s. Thus, our study suggests that cigarette smoking increases local and circulating frequencies of activated ILC3 cells, plays a role in their activation, thereby aggravating non-allergic inflammation and the severity of asthma.

1 May 2021 in Molecules and Cells
Verified
Journal Article
Open access
PDF file
JKJihyun Kim
Jihyun Kim
SRSeungwon Ryu
Seungwon Ryu
HKHye Young Kim
Hye Young Kim
Jihyun Kim, Seungwon Ryu, and Hye Young Kim. Mol. Cells 2021;44:301-9. https://doi.org/10.14348/molcells.2021.0053

1 January 2020 in Asia Pacific Allergy
Verified
Journal Article
Open access
PDF file
SKSung-Yoon Kang
Sung-Yoon Kang
JKJihyun Kim
Jihyun Kim
JHJongho Ham
Jongho Ham
SCSang-Heon Cho
Sang-Heon Cho
HKHye-Ryun Kang
Hye-Ryun Kang
HKHye Young Kim
Hye Young Kim
Kang SY, et al. Asia Pac Allergy. 2020 Jan;10:e2. https://doi.org/10.5415/apallergy.2020.10.e2

16 April 2020 in Allergy
Verified
Journal Article
Closed access
PDF file
JKJihyun Kim
Jihyun Kim
YKYoung‐Chan Kim
Young‐Chan Kim
JHJongho Ham
Jongho Ham
KSKyoung‐Hee Sohn
Kyoung‐Hee Sohn
SLSuh Young Lee
Suh Young Lee
HKHye Young Kim
Hye Young Kim